Status:
TERMINATED
Comparison of Different Up-dosing Schedules With Osiris
Lead Sponsor:
ALK-Abelló A/S
Conditions:
Allergic Rhinitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare different up-dosing schedules with Osiris.
Eligibility Criteria
Inclusion
- history of grass pollen allergy
- Positive SPT to grass
- Positive IgE to grass
Exclusion
- uncontrolled and severe asthma
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01240954
Start Date
December 1 2010
Last Update
August 29 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Krakow, Poland